Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 26 Issue 7, July 2025

Inspired by the Review on p443

Cover design: Patrick Morgan

Comment

  • Despite their immense potential, gene and cell therapies that target rare diseases are at risk of market withdrawal, owing to several challenges. The authors describe these hurdles and call for innovative measures to improve the economic sustainability of gene and cell therapies after regulatory approval.

    • Celeste Scotti
    • Alessandro Aiuti
    • Luigi Naldini
    Comment

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

Journal Club

Top of page ⤴

Reviews

  • In this Review, Dowdle and Lykke-Andersen discuss advances in our understanding of the machinery and mechanisms involved in the control of cytoplasmic mRNA decay and comment on implications for the design of therapeutic mRNAs.

    • Megan E. Dowdle
    • Jens Lykke-Andersen
    Review Article
  • In this Review, Isomura and Kageyama discuss how advances in live imaging, stem cell technologies and synthetic approaches are providing insights into the mechanisms underlying synchronization and species-specific periodicity of the mammalian segmentation clock during somitogenesis.

    • Akihiro Isomura
    • Ryoichiro Kageyama
    Review Article
  • This Review explores how experimental models of metastasis, such as mouse models and cell cultures, can complement the (multi)omics analysis of human metastasis samples, thereby filling knowledge gaps left by model studies and validating the findings from human sequencing data.

    • Michelle M. Leung
    • Charles Swanton
    • Nicholas McGranahan
    Review Article
Top of page ⤴

Search

Quick links